Therapeutic vaccines in HBV: lessons from HCV

Currently, millions of people infected with hepatitis B virus (HBV) are committed to decades of treatment with anti-viral therapy to control viral replication. However, new tools for immunotherapy that include both viral vectors and molecular checkpoint inhibitors are now available. This has led to...

詳細記述

書誌詳細
第一著者: Barnes, E
フォーマット: Journal article
言語:English
出版事項: Springer Berlin Heidelberg 2015